Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
View Standalone
View Standalone
Bio Medica Laboratories Ltd (BMLL) is currently trading at 160.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Bio Medica Laboratories Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Bio Medica Laboratories Ltd has traded between a low of ₹101.50 and a high of ₹181.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Bio Medica Laboratories Ltd has a market capitalization of approximately 200.76. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Bio Medica Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 16.74 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 200.76 Cr, Bio Medica Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Bio Medica Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Bio Medica Laboratories Ltd is 16.74. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
1
Neutral
8
Bullish
5
Bearish
8
Neutral
20
Bullish
18
Bearish
7
Neutral
12
Bullish
13
Bearish
1
Neutral
8
Bullish
5
Bearish
1
Neutral
8
Bullish
5
Bearish
7
Neutral
12
Bullish
13
Bearish
7
Neutral
12
Bullish
13
Bearish
7
Neutral
12
Bullish
13
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
195.00 | 209 Cr | -8.43 | 1.20 | 0.00 | -7.27 | -4.85 | -5.85 | ||
54.38 | 205 Cr | -15.12 | 0.00 | 0.00 | 41.16 | -26.02 | -11.34 | ||
580.00 | 204 Cr | 10.60 | 0.97 | 0.35 | 7.83 | 10.89 | 7.98 | ||
282.00 | 202 Cr | 40.24 | 5.69 | 0.00 | 14.29 | 16.99 | 12.01 | ||
160.45 | 201 Cr | 16.74 | 2.72 | 0.00 | 45.24 | 27.08 | 16.22 | ||
167.50 | 189 Cr | 25.29 | 2.57 | 0.91 | 5.54 | 8.84 | 7.16 | ||
63.00 | 188 Cr | 14.26 | 1.54 | 0.00 | 20.04 | 19.30 | 8.92 | ||
| Median: 7 Co. | — | 167.50 | 202 Cr | 14.26 | 1.54 | 0.00 | 14.29 | 10.89 | 7.98 |
Pharmaceuticals & Biotechnology
Pharmaceuticals
201 Cr
High Risk
16.7
37.7
0.1
2.7
181.00
101.50
Sales CAGR
Profit CAGR
ROE
ROCE
AGM/EGM Notice
Bio Medica Laboratories Ltd published a newspaper notice under Reg 47 for its 11th AGM to be held on 2026-09-28 at 14:00 IST via VC/OAVM; notice available on company website.
AGM/EGM Notice
Bio Medica Laboratories Ltd: Notice of 11th AGM on 2026-09-28 at 14:00 IST via VC/OAVM. Agenda includes adopting audited FY2025-26 financials, reappointment of director, appointment of secretarial auditor, and increase of FPI limit to 49%.
